Seeing Is Believing
Gracell Biotechnologies's activity chart (see below) currently has 24 price targets and 24 ratings on display.
Analysts average stock forecasts to be materialized ratio is 70% with an average time for these price targets to be met of 376.2 days.
Most recent stock forecast was given by from WELLS FARGO on 28-Dec-2023. First documented stock forecast 02-Feb-2021.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 27-Mar-2023
$10
2 years 10 months 12 days ago
(28-Dec-2023)
2/2 (100%)
$0.08 (0.81%)
138
Buy Since 30-Apr-2021
$10
$-0.25 (-2.44%)
$10
2 years 10 months 13 days ago
(27-Dec-2023)
3/6 (50%)
$0.08 (0.81%)
261
Buy Since 08-Dec-2022
$10
$-0.25 (-2.44%)
$13
2 years 10 months 14 days ago
(26-Dec-2023)
2/4 (50%)
$0.08 (0.81%)
95
Buy Since 04-Apr-2022
$20
2 years 10 months 14 days ago
(26-Dec-2023)
0/2 (0%)
$13.93 (229.49%)
Buy Since 19-Oct-2023
$11
3 years 21 days ago
(19-Oct-2023)
0/2 (0%)
$8.4 (323.08%)
What is GRCL (Gracell Biotechnologies) average time for price targets to be met?
Which analyst most recently updated their price target on GRCL (Gracell Biotechnologies)?
Which analyst has the most public recommendations on GRCL (Gracell Biotechnologies)?
Which analyst is the currently most bullish on GRCL (Gracell Biotechnologies)?
Which analyst is the currently most reserved on GRCL (Gracell Biotechnologies)?